FDA Inspection 592023 — Bioserv Corporation

Bioserv Corporation — FEI 2027352

The FDA completed an inspection of Bioserv Corporation on June 24, 2009 in San Diego, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 24, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
San Diego, CA (United States)